Status:
COMPLETED
Filipino Multicomponent Intervention to Maintain Cognitive Performance in High Risk Population (FINOMAIN)
Lead Sponsor:
St. Luke's Medical Center, Philippines
Collaborating Sponsors:
Nanyang Technological University
Icahn School of Medicine at Mount Sinai
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
FINOMAIN is a community-based, cluster randomized controlled trial (cRCT) of dance intervention INDAK and standardized vascular care. The study aims to develop and assess the effectiveness of a cost-e...
Detailed Description
FINOMAIN is a single-blind (assessor blinded), community-based, cluster randomized controlled trial (cRCT) of a multi-component intervention with two arms. The intervention arm will receive 12 months ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Aged ≥ 60 years old
- Mild cognitive impairment (MCI) based on Petersen criteria
- Standardized cognitive test ≥1.5 standard deviation (SD) below norms
- Do not fulfill DSM-V criteria for major cognitive disorders
- Clinical Dementia Rating (CDR) of 0.5
- Exclusion criteria:
- Significant functional impairment based on Lawton's IADL
- Significant neuropsychiatric impairment based on NPI-Q
- Significant hearing and visual impairment that limit testing and dance participation
- Pre-existing illness that in the judgment of the study physician precludes engagement in moderate physical activity
Exclusion
Key Trial Info
Start Date :
May 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04301544
Start Date
May 28 2019
End Date
December 30 2020
Last Update
October 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Neurosciences, St. Luke's Medical Center
Quezon City, National Capital Region, Philippines, 1102